What targeted therapies are available for Lymphoma

Targeted Therapies for Lymphoma

Targeted therapies are treatments designed to attack specific features of lymphoma cells—like particular proteins or genetic mutations—rather than harming all rapidly dividing cells. This approach can be more effective and sometimes causes fewer side effects than traditional chemotherapy.

How Doctors Think About Targeted Therapy

According to NCCN Guidelines, oncologists first identify specific mutations or proteins in your lymphoma cells through biomarker testing. As the NCCN Guidelines for Marginal Zone Lymphomas explain, "Some mutations can be targeted with specific therapies." Your doctor then matches these findings to available targeted treatments.

The key principle: different lymphoma types have different targetable features, so the right therapy depends on what mutations or proteins your specific cancer cells have.

Major Categories of Targeted Therapies

1. CD19-Targeted CAR T-Cell Therapy

This is a revolutionary approach for aggressive lymphomas. According to recent medical literature, anti-CD19 CAR T-cell therapy is now considered standard of care for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma after 2 or more lines of therapy.

Three FDA-approved CAR T products are available:

• Axicabtagene ciloleucel
• Tisagenlecleucel
• Lisocabtagene maraleucel

These therapies have shown unprecedented response rates in patients whose lymphoma didn't respond to or came back after other treatments. CAR T therapy works by genetically modifying your own immune cells to recognize and attack lymphoma cells.

2. Targeted Therapies for Specific Mutations

The NCCN Guidelines note that mutation testing looks for specific genetic changes in lymphoma cells, including:

• Deletions (missing parts of genes)
• Translocations (gene rearrangements)
• Point mutations (single gene changes)
• Amplifications (duplicated genes)

Different mutations respond to different targeted drugs. For example, certain mutations in genes like ALK (anaplastic lymphoma kinase) have specific targeted therapies available.

3. Immunotherapy and Monoclonal Antibodies

These drugs target specific proteins on lymphoma cell surfaces. They help your immune system recognize and destroy cancer cells more effectively.

Important Next Steps

However, YOUR specific situation requires your doctor's evaluation. The right targeted therapy depends on:

1. What type of lymphoma do you have? (Follicular, DLBCL, Marginal Zone, Mantle Cell, etc.)
2. What mutations or proteins does your lymphoma have? (This requires biomarker testing)
3. What treatments have you already received?
4. What is your overall health status?

Questions to Ask Your Oncology Team

1. What biomarker or mutation testing has been done on my lymphoma cells?
2. Based on my specific test results, which targeted therapies are options for me?
3. Am I a candidate for CAR T-cell therapy, and if so, what would that involve?
4. What are the benefits and potential side effects of the targeted therapies you're recommending?
5. Are there clinical trials available for targeted therapies that might be appropriate for my situation?

Finding More Information

The NCCN Guidelines for Patients (available free at nccn.org) provide detailed information specific to your lymphoma type. The Lymphoma Research Foundation (lymphoma.org) also offers excellent patient education resources about targeted treatments.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.